Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermatogenesis-associated protein 31D1 is a member of the SPATA31 gene family, which is predicted to play a role in spermatogenesis and may be involved in cell differentiation[1]. Its molecular classification is not fully defined, but it is not a receptor, enzyme, transporter, ion channel, or established transcription factor; some data suggest it may act as a transcription cofactor and participate in protein-protein interactions[2]. The gene is primarily expressed in testis and spermatozoa and is enriched in reproductive tissues[9]. Some studies report expression in human cancers, but there is no direct evidence for a role in disease progression or as a therapeutic target[4]. There are no known drugs targeting this protein, nor is there evidence of a defined mechanism of action for pharmacological modulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatogenesis-associated protein 31D1 (SPATA31D1).